TandemAI
PrivateLast Round
Series A
Extension
Nov 13, 2025
Total Funding Raised
$82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TandemAI is a biotechnology company that offers an advanced network platform combining AI-driven computation with large-scale wet lab operations to enhance the speed and affordability of drug discovery for the global scientific community.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TandemAI Comparables
Compare TandemAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iktos | 83% | |
| Inductive Bio | 82% | |
| Fathom Therapeutics | 82% |
TandemAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 13, 2025 | ||||
| Series A | Mar 1, 2023 | ||||
| Seed | Dec 22, 2021 |
Key People
Founding team and executive leadership
TandemAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHK & Partners | Series A Extension |
| V-Capital | Series A Extension |
| F-Prime Capital | Series A |
| Eight Roads Ventures | Series A |
| OrbiMed | Series A, Seed |
| Chengwei Capital | Seed |
| F-Prime Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Added Contract Pharma, a media/publishing SMB, as a customer.
- Nov 13, 2025
Raised $22M in a Series A Extension round.
TandemAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TandemAI's valuation, stock price, and market status.
Is TandemAI a public or private company?
TandemAI is a private company.
What is the current stock price of TandemAI?
TandemAI is a private company with no public stock price. No recent secondary market data is available.
How much is TandemAI worth (valuation)?
Valuation information for TandemAI is not publicly available.
Can I buy TandemAI stock?
TandemAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TandemAI's last funding round?
TandemAI's most recent funding round was Series A Extension on November 13, 2025.
Who are the main investors in TandemAI?
Key investors in TandemAI include KHK & Partners, V-Capital, OrbiMed, Chengwei Capital, Qiming Venture Partners.
Will TandemAI IPO soon?
No public IPO plans have been announced for TandemAI.
How can I track TandemAI secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TandemAI's secondary market activity and sign up for updates.